Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 3

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04090359Phase 4Recruiting

Dual Mobility Acetabular Cups in Revision TJA

Role: collaborator

NCT05521919Not ApplicableCompleted

Acute Plasma Abeta Responses to Stress

Role: collaborator

NCT07219862Not ApplicableNot Yet Recruiting

Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization

Role: lead

NCT04092634Phase 4Active Not Recruiting

Dual Mobility in "High Risk" Patients

Role: collaborator

NCT06351215Phase 3Not Yet Recruiting

PO Methadone Ortho Outpatient

Role: lead

NCT05961670Unknown

Application of Lung Near-Infrared Spectroscopy (NIRS) in Preterm Infants

Role: lead

NCT05961683Not ApplicableUnknown

Evaluating Pressures During Non-invasive Ventilation Utilizing NIV Plus Software

Role: lead

All 7 trials loaded